Patient
SITE002-0237
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE002 (USA) (Dr. Nolan)
consented 2026-06-03
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-07-25
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-18 (study day 32); relationship: not assessed
severe
assessed
2026-07-08
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-01 (study day 15); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.